Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-11-14FDA Approved: NASAL ALLERGY — Supplemental Application (Kroger Company)
The FDA approved a supplemental application for the Kroger Company's NASAL ALLERGY product containing Triamcinolone Acetonide (ANDA078104).
-
FDA approval · 2014-11-07FDA Approved: HIVES RELIEF — Supplemental Application (WALGREEN COMPANY)
FDA approved a supplemental application for HIVES RELIEF, a cetirizine hydrochloride tablet product from Walgreens Company. The approval cov…
-
FDA approval · 2014-11-07FDA Approved: LORATADINE — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental application for loratadine from Lannett Company, expanding the availability of this generic antihistamine.
-
FDA approval · 2014-11-05FDA Approved: HIVES RELIEF — Supplemental Application (WALGREEN COMPANY)
FDA approved a supplemental application for HIVES RELIEF, a cetirizine tablet product from Walgreens. Cetirizine is used to treat allergic s…
-
FDA approval · 2014-10-29FDA Approved: DYMISTA — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for DYMISTA (azelastine hydrochloride and fluticasone propionate) from Viatris Specialty LLC, under …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-10-21FDA Approved: ALLERGY AND CONGESTION RELIEF — Supplemental Application (L. Perrigo Company)
The FDA approved a supplemental application for an allergy and congestion relief product containing loratadine and pseudoephedrine sulfate b…
-
CLINICAL_TRIALS trial_result · 2014-10-20Clinical Trial Update: To Investigate the Safety, Pharmacodynamics and Effect on Allergic Reactivity of the Toll-like Receptor 7 (TLR7) Agonist GSK2245035 in Subjects With Respiratory Allergies [Phase 2]
A Phase 2 trial investigated the safety, pharmacodynamics, and effect on allergic reactivity of the Toll-like Receptor 7 agonist GSK2245035 …
-
CLINICAL_TRIALS trial_result · 2014-10-08Clinical Trial Update: A Proof of Concept Study to Assess Effect of Fluticasone Furoate (FF)/Levocabastine Fixed Dose Combination (FDC) Compared With Levocabastine and FF Alone in Subjects With Allergic Rhinitis (AR) [Phase 2]
Phase 2 trial evaluating a fixed-dose combination of fluticasone furoate and levocabastine versus levocabastine and fluticasone furoate alon…
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: A Study to Assess Intranasal Repeat Dose Effect of Levocabastine in the Subjects With Allergic Rhinitis [Phase 2]
Phase 2 trial evaluating intranasal repeat-dose levocabastine in subjects with allergic rhinitis (perennial and seasonal); results were comp…
-
FDA label_change · 2014-09-19FDA Approved: NASACORT ALLERGY 24HR — Supplemental Application (Chattem, Inc.)
FDA note of a supplemental application for Nasacort Allergy 24HR (triamcinolone acetonide) by Chattem, Inc., likely supporting labeling chan…
-
FDA approval · 2014-09-12FDA Approved: ALLEGRA HIVES 24HR — Supplemental Application (Chattem, Inc.)
The FDA approved a supplemental application for Allegra Hives 24HR (fexofenadine hydrochloride) submitted by Chattem, Inc., likely updating …
-
CLINICAL_TRIALS trial_result · 2014-09-12Clinical Trial Update: Post Marketing Surveillance of Alesion® in Japanese Paediatric Patients With Allergic Rhinitis, Eczema/Dermatitis, Urticaria and Pruritus
Post-marketing surveillance of Alesion in Japanese pediatric patients with allergic rhinitis, atopic dermatitis (eczema/dermatitis), urticar…
-
CLINICAL_TRIALS trial_result · 2014-09-12Clinical Trial Update: Safety Trial of Atrovent® in Pediatric Patients With Rhinorrhea Associated With a Common Cold or Allergy [Phase 4]
A completed Phase 4 safety trial evaluating the nasal spray Atrovent (ipratropium bromide) in pediatric patients with rhinorrhea associated …
-
FDA approval · 2014-09-10FDA Approved: MONTELUKAST — Original Application (XLCare Pharmaceuticals Inc.)
FDA approves the original abbreviated new drug application for Montelukast (generic) submitted by XLCare Pharmaceuticals Inc.
-
FDA approval · 2014-09-09FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Original Application (Vensun Pharmaceuticals, Inc.)
FDA approved the original application (ANDA) for levocetirizine dihydrochloride by Vensun Pharmaceuticals, Inc., providing a generic version…
-
CLINICAL_TRIALS research · 2014-09-08Clinical Trial Update: Effect of Hypertonic Solutions on Allergic Rhinitis Patients
A clinical trial update from Namik Kemal University exploring the effect of hypertonic solutions in patients with allergic rhinitis; the cur…
-
CLINICAL_TRIALS trial_result · 2014-08-26Clinical Trial Update: Open Study to Evaluate the Safety of Levocetirizine in Young Children (2 - 6 Years) Suffering From Allergic Rhinitis [Phase 2]
Phase 2 open-label study evaluating the safety of levocetirizine in children aged 2-6 with allergic rhinitis has completed.
-
FDA approval · 2014-08-19FDA Approved: GOOD NEIGHBOR PHARMACY CHILDRENS LORATADINE — Supplemental Application (AmerisourceBergen)
FDA approved a supplemental application for Good Neighbor Pharmacy Children's Loratadine (loratadine) from AmerisourceBergen. The approval i…
-
CLINICAL_TRIALS trial_result · 2014-08-12Clinical Trial Update: The Role of Th9 Cells and Eosinophils Activity in Allergic Airway Diseases
A clinical trial update examines the role of TH9 cells and eosinophil activity in allergic airway diseases, including allergic asthma and al…
-
FDA approval · 2014-07-25FDA Approved: CLARITIN CHEWABLE GRAPE AND BUBBLEGUM — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application for Claritin Chewable Grape and Bubblegum containing loratadine, expanding the product line with a n…
-
FDA approval · 2014-07-23FDA Approved: CHILDRENS FLONASE ALLERGY RELIEF — Original Application (Haleon US Holdings LLC)
FDA approved the original application for Children's Flonase Allergy Relief (fluticasone propionate) by Haleon US Holdings LLC.
-
FDA approval · 2014-07-22FDA Approved: CLARITIN REDITABS — Supplemental Application (Bayer HealthCare LLC)
FDA approved a supplemental NDA for Claritin RediTabs (loratadine) by Bayer HealthCare LLC.
-
FDA approval · 2014-07-22FDA Approved: CLARITIN REDITABS — Supplemental Application (Bayer Healthcare LLC.)
FDA approved a supplemental application for Claritin RediTabs (loratadine) from Bayer Healthcare LLC, updating the approved formulation. Lor…
-
CLINICAL_TRIALS trial_result · 2014-07-14Clinical Trial Update: Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet in Adults With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (Study P05233)(COMPLETED) [Phase 2, Phase 3]
Completed Phase 2/3 trial evaluating the efficacy and long-term safety of a ragweed pollen sublingual tablet in adults with ragweed-induced …
-
FDA approval · 2014-07-10FDA Approved: QNASL — Supplemental Application (Teva Respiratory, LLC)
FDA approved a supplemental application for QNASL (beclomethasone dipropionate) from Teva Respiratory, LLC.